The immune response induced by a split influenza vaccine. Studies on cellular immunity. 1997

V Alexandrescu, and G Manda, and M Neagu, and D Ciotaru, and E Ioniţă
Influenza Virus Department, Cantacuzino Institute, Bucharest, Romania.

The aim of this study is to evaluate the effects exerted in vivo upon the general reactivity of the immune system by a commercial split influenza vaccine produced by the Cantacuzino Institute, Bucharest-Romania. The vaccine was intramuscularly administered to 14 volunteers with no precedent of influenza vaccination and no major immune disorders. We have investigated in vitro the polyclonal proliferation of peripheral lymphocytes and the phagocytosis developed by peripheral granulocytes, before and three weeks after vaccination. Our experimental results indicate that the vaccine might have a modulatory action on peripheral leukocyte concentration induces the activation of polyclonal lymphocyte proliferation and of the phagocytosis potential of granulocytes. These effects are not dependent on the age of the vaccinees.

UI MeSH Term Description Entries
D007111 Immunity, Cellular Manifestations of the immune response which are mediated by antigen-sensitized T-lymphocytes via lymphokines or direct cytotoxicity. This takes place in the absence of circulating antibody or where antibody plays a subordinate role. Cell-Mediated Immunity,Cellular Immune Response,Cell Mediated Immunity,Cell-Mediated Immunities,Cellular Immune Responses,Cellular Immunities,Cellular Immunity,Immune Response, Cellular,Immune Responses, Cellular,Immunities, Cell-Mediated,Immunities, Cellular,Immunity, Cell-Mediated,Response, Cellular Immune
D007252 Influenza Vaccines Vaccines used to prevent infection by viruses in the family ORTHOMYXOVIRIDAE. It includes both killed and attenuated vaccines. The composition of the vaccines is changed each year in response to antigenic shifts and changes in prevalence of influenza virus strains. The flu vaccines may be mono- or multi-valent, which contains one or more ALPHAINFLUENZAVIRUS and BETAINFLUENZAVIRUS strains. Flu Vaccine,Influenzavirus Vaccine,Monovalent Influenza Vaccine,Universal Flu Vaccine,Universal Influenza Vaccine,Flu Vaccines,High-Dose Trivalent Influenza Vaccine,Influenza Vaccine,Influenza Virus Vaccine,Influenza Virus Vaccines,Influenzavirus Vaccines,Intranasal Live-Attenuated Influenza Vaccine,LAIV Vaccine,Monovalent Influenza Vaccines,Quadrivalent Influenza Vaccine,Trivalent Influenza Vaccine,Trivalent Live Attenuated Influenza Vaccine,Universal Flu Vaccines,Universal Influenza Vaccines,Flu Vaccine, Universal,High Dose Trivalent Influenza Vaccine,Influenza Vaccine, Monovalent,Influenza Vaccine, Quadrivalent,Influenza Vaccine, Trivalent,Influenza Vaccine, Universal,Intranasal Live Attenuated Influenza Vaccine,Vaccine, Flu,Vaccine, Influenza,Vaccine, Influenza Virus,Vaccine, Influenzavirus,Vaccine, LAIV,Vaccine, Monovalent Influenza,Vaccine, Quadrivalent Influenza,Vaccine, Trivalent Influenza,Virus Vaccine, Influenza
D007958 Leukocyte Count The number of WHITE BLOOD CELLS per unit volume in venous BLOOD. A differential leukocyte count measures the relative numbers of the different types of white cells. Blood Cell Count, White,Differential Leukocyte Count,Leukocyte Count, Differential,Leukocyte Number,White Blood Cell Count,Count, Differential Leukocyte,Count, Leukocyte,Counts, Differential Leukocyte,Counts, Leukocyte,Differential Leukocyte Counts,Leukocyte Counts,Leukocyte Counts, Differential,Leukocyte Numbers,Number, Leukocyte,Numbers, Leukocyte
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010587 Phagocytosis The engulfing and degradation of microorganisms; other cells that are dead, dying, or pathogenic; and foreign particles by phagocytic cells (PHAGOCYTES). Phagocytoses
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

V Alexandrescu, and G Manda, and M Neagu, and D Ciotaru, and E Ioniţă
November 2015, Vaccine,
V Alexandrescu, and G Manda, and M Neagu, and D Ciotaru, and E Ioniţă
January 2017, Clinical and vaccine immunology : CVI,
V Alexandrescu, and G Manda, and M Neagu, and D Ciotaru, and E Ioniţă
December 2007, Pediatric blood & cancer,
V Alexandrescu, and G Manda, and M Neagu, and D Ciotaru, and E Ioniţă
January 1988, Virologie,
V Alexandrescu, and G Manda, and M Neagu, and D Ciotaru, and E Ioniţă
January 1992, Vaccine,
V Alexandrescu, and G Manda, and M Neagu, and D Ciotaru, and E Ioniţă
September 1979, Tissue antigens,
V Alexandrescu, and G Manda, and M Neagu, and D Ciotaru, and E Ioniţă
February 2020, Cellular immunology,
V Alexandrescu, and G Manda, and M Neagu, and D Ciotaru, and E Ioniţă
November 2009, Vaccine,
V Alexandrescu, and G Manda, and M Neagu, and D Ciotaru, and E Ioniţă
January 2019, Frontiers in microbiology,
V Alexandrescu, and G Manda, and M Neagu, and D Ciotaru, and E Ioniţă
April 2020, Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia,
Copied contents to your clipboard!